Hiromasa Inoue

Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial

H. Inoue, H. Suna, T. Kawayama, 2019 .

Impact of extrapulmonary comorbidities on physical activity in chronic obstructive pulmonary disease in Japan: A cross-sectional study

T. Iwanaga, T. Hiramoto, Atsushi Moriwaki, 2022, PloS one.

Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial

S. Fuke, T. Ishida, J. Terada, 2022, American journal of respiratory and critical care medicine.

Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update

J. Drazen, L. Boulet, E. Bateman, 2023, npj Primary Care Respiratory Medicine.

Global Initiative for Asthma Strategy 2021

J. Drazen, L. Boulet, E. Bateman, 2022 .

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD

Sudhir R Parikh, I. Pavord, Wei Zhang, 2023, Respiratory Research.